Cure My Disease

Don't miss your cure!

 Log in / Sign up

MS patients can safely get infusions at home, new study shows

NCT ID NCT04777539

Completed Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether it is safe for people with multiple sclerosis to receive their natalizumab (Tysabri) infusions at home instead of at a hospital. Researchers compared serious side effects, quality of life, and costs over one year in 295 patients. The goal was to see if home treatment is a good option for managing MS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, MS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS, MS

Contacts and locations

Locations

  • AP-HP La Pitié-Salpêtrière Hospital

    Paris, Paris, 75000, France

  • Adolphe de Rothschild Ophthalmological Foundation

    Paris, Paris, 75000, France

  • Bordeaux University Hospital

    Bordeaux, Gironde, 33000, France

  • Brest University Hospital

    Brest, Finistère, 29200, France

  • CH Ajaccio

    Ajaccio, France

  • CHU Grenoble Alpes

    La Tronche, 38700, France

  • Hôpital St Vincent de Paul

    Lille, 59020, France

  • Les Hôpitaux de Chartres

    Chartres, France

  • Libourne Hospital

    Libourne, Gironde, 33500, France

  • Lille University Hospital

    Lille, Nord, 59000, France

  • Marseille University Hospital

    Marseille, Bouches-du-Rhône, 13000, France

  • Nantes University Hospital

    Nantes, Loire-Atlantique, 44000, France

  • Orléans Hospital

    Orléans, Loiret, 45000, France

  • Percy Army Training Hospital

    Clamart, Hauts-de-Seine, 92140, France

  • Poitiers University Hospital

    Poitiers, Vienne, 86000, France

  • Rennes University Hospital

    Rennes, Ille-et-Vilaine, 35000, France

  • Rouen University Hospital

    Rouen, Seine-Maritime, 76000, France

  • Saint-Nazaire Hospital Center

    Saint-Nazaire, 44606, France

  • Strasbourg University Hospital

    Strasbourg, Bas-Rhin, 67000, France

  • Toulouse University Hospital

    Toulouse, Haute-Garonne, 31000, France

  • Tours University Hospital

    Tours, Indre-et-Loire, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.